66 2021 ESG Report Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Appendices Photo: Kenya, September 2020 Statistics courtesy of UNICEF USA How we expand healthcare access and equity...globally Each year, 18.6 million people die due to lack of access to surgical care, 93 percent of whom are in Africa. As the fragile healthcare systems in African nations continue to recover from the impacts of the COVID-19 pandemic, the need to provide basic life-saving surgical care is greater than ever. Over the past 28 years, BD has donated more than $2.5 million in cash and product to Mercy Ships to support its mission of bringing free, safe surgical care to Africans in need, aboard its unique “floating hospital” ships. BD also provides philanthropic support to the Royal College of Surgeons (RCSI), Ireland, to help it expand surgical access to 8 million children in Malawi, and to help Operation Smile deliver cleft palate surgeries, globally. Advancing maternal health and reducing avoidable newborn deaths, globally 80% 161M of countries identified as “high risk” in 1999 have achieved elimination of the disease Neonatal tetanus kills 1 newborn every 21 minutes — but it is highly preventable women have been immunized against tetanus since 1999 Tetanus toxoid vaccine confers immunity for the first month of life to a child born to an immunized woman Although maternal and neonatal tetanus (MNT) has been all but eliminated in most economically advanced countries, it still kills one newborn every 21 minutes, or approximately 68 newborns every day. Knowing that MNT is entirely preventable with immunizations and consistent health services for mothers, BD began supporting UNICEF’s neonatal tetanus immunization program in 1997. The program ensures that mothers in remote geographic regions that experience high rates of MNT have access to life-saving immunizations and gynecological care. Since the inception of the program in 1997, with the help of $10.8 million in funding from BD, newborn deaths from MNT have declined by 88 percent. Collaborating with governments, leading agencies and NGOs to strengthen health systems BD, PEPFAR and CDC public-private partnerships BD has established a series of partnerships with the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and the U.S. Center for Disease Control (CDC) and ministries of health. These partnerships help us strengthen laboratory systems and upgrade clinical practices in blood culture specimen collection, phlebotomy, infusion and injection. Enhancing healthcare workers’ and patients’ safety in Kenya in partnership with PEPFAR, CDC Kenya and Kenya’s ministry of health In September 2021, as part of BD’s long-standing partnership with PEPFAR, CDC Kenya and the Kenya ministry of health (MOH), the first ever blood culture specimen management training for healthcare workers was conducted to enhance their safety and patients’ safety. The training curriculum—which was prepared by BD and reviewed and adopted by CDC and MOH—included topics such as introduction to antimicrobial resistance (AMR) and sepsis, safe blood culture collection and preparation of blood cultures, the blood culture sample pathway and diagnosis of catheter-related blood stream infection (CRBSI). Due to the COVID-19 pandemic travel restrictions, the training used a mixed methodology of virtual and in-person training. Over 40 participants from 12 facilities across Kenya were trained in two separate two-day training sessions. “Antimicrobial resistance has become a global challenge and Kenya is not spared. Antimicrobial stewardship programs are being scaled up in Kenya and they recommend the use of blood culture for diagnosis. Proper collection and management of the blood culture specimen is critical for correct diagnosis. This training, therefore, came at the right point in time and was really appreciated. The MOH hopes to scale this up in future.” Dr Daniel Kimani Technical Advisor, Laboratory, Health Systems and Infection Control. CDC, Nairobi, Kenya “Currently, there are no guidelines for Kenyan hospitals on how to identify and collect blood specimens from suspected sepsis patients. This was a tremendous opportunity to capacity build the clinicians, nurses and laboratory personnel who are responsible for implementing best practices in their respective hospitals across the selected counties in Kenya.” Timons Sigo BD Senior Clinical Resource Consultant, Nairobi, Kenya